Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)Arnaud Jaccard, Chris Venner, Philip N. Hawkins et al.|Haematologica|2014Cited by 129